Biodexa Pharmaceuticals PLC

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Biodexa Pharmaceuticals PLC had 2.94M in cash and cash equivalents.

Biodexa Pharmaceuticals PLC reported 8.98M in total liabilities as of the latest reported quarter, including 8.12M in current liabilities and 855.01K in non-current liabilities.

As of the latest reported quarter, Biodexa Pharmaceuticals PLC's total assets were 24.10M, consisting of 16.49M in current assets and 7.60M in non-current assets.

Biodexa Pharmaceuticals PLC reported 8.60M in total shareholders' equity as of the latest reported quarter.